miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
about
MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review).c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.Identification of a functional polymorphism affecting microRNA binding in the susceptibility locus 1q25.3 for colorectal cancer.Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasmaCombinations of elevated tissue miRNA-17-92 cluster expression and serum prostate-specific antigen as potential diagnostic biomarkers for prostate cancer.miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer.MiR-29a: a potential therapeutic target and promising biomarker in tumors.LAMC1 mRNA promotes malignancy of hepatocellular carcinoma cells by competing for MicroRNA-124 binding with CD151.MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis.
P2860
Q36349912-94DC0092-62E7-4192-8937-39ACD1F1755CQ36887594-22EBE7EF-82EF-4F36-95AB-FCDE4BC4598BQ37588086-E2454193-86DF-45C9-BB40-EC4A7DD55D51Q37688990-7D680717-9478-46DC-8927-6A19CE41E8BEQ38715226-4800393C-6AD6-463E-BCA1-BEDE1E8BA9ECQ38816103-0C9027AC-D9F1-4D62-BFD6-8B841D44D113Q40300140-F4E0CCFA-0D0F-4DB6-B666-83708AED0287Q41552378-812B570A-1AF3-49F1-8133-ACC9F8C3997CQ47110388-B64B475D-CA82-4CD3-BF23-93F082288398Q47380679-6452DD7D-D3D2-4D88-A66F-179CA35BD3F1Q47568135-3FD228C1-E4E2-4DF0-90FE-AB78EE5200FFQ48121743-465B93B6-1A61-4E1B-91DB-EF8FDC988609Q50068790-7FB8B3D2-8999-4C73-B1DB-B7DA760A91E3
P2860
miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
miR-22 and miR-29a Are Members ...... and Mcl-1 in Prostate Cancer.
@ast
miR-22 and miR-29a Are Members ...... and Mcl-1 in Prostate Cancer.
@en
type
label
miR-22 and miR-29a Are Members ...... and Mcl-1 in Prostate Cancer.
@ast
miR-22 and miR-29a Are Members ...... and Mcl-1 in Prostate Cancer.
@en
prefLabel
miR-22 and miR-29a Are Members ...... and Mcl-1 in Prostate Cancer.
@ast
miR-22 and miR-29a Are Members ...... and Mcl-1 in Prostate Cancer.
@en
P2093
P2860
P50
P356
P1476
miR-22 and miR-29a Are Members ...... 1 and Mcl-1 in Prostate Cancer
@en
P2093
Bettina Schlick
Georg Schäfer
Helmut Klocker
Martin Puhr
Michal R Schweiger
Narisu Narisu
Stefan T Börno
Zlatko Trajanoski
P2860
P304
P356
10.1210/ME.2014-1358
P577
2015-06-08T00:00:00Z